Thrombolysis' benefits on early post-stroke language recovery in aphasia patients.


Journal

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 24 06 2019
accepted: 07 08 2019
pubmed: 24 8 2019
medline: 6 2 2020
entrez: 24 8 2019
Statut: ppublish

Résumé

Thrombolysis may affect ischemic stroke-related size, pattern and nature of infarcts, and has the potential to change aphasia presentation and recovery. Data on evolution of post-stroke aphasia following thrombolysis are still scarce. The aim of this study was to determine the course of language recovery through a well-validated language assessment battery after acute ischemic stroke and investigate whether traditional categorical classifications of aphasia can describe the clinical picture in post-thrombolysis phase. Demographic, clinical, and language assessment data of 116 patients presenting sub-acute ischemic stroke aphasia (41 treated with r-tPA; 75 non-treated) were retrospectively analyzed. The participants were assessed by a clinical neuropsychologist with a variety of subtests taken from a well-validated Italian language battery (Neuro-Psychological Aphasia Evaluation). The percentage of resolved aphasia was significantly higher in treated patients compared to non-treated patients (p = 0.005) and global aphasia was more common in the non-treated group (non-treated 30.7% vs treated 17.1%). Aphasia subtypes and stroke etiologies showed no significant association, except for small vessel etiology and resolved aphasia (p = 0.041). Reperfusion treatment, baseline NIHSS, and lacunar stroke were the predictors of aphasia recovery. The percentage of resolved aphasia was significantly higher in the treated patients compared to the non-treated, with the latter showing a higher percentage of global aphasia. Identifying classic aphasia subtypes after thrombolysis is still possible since reperfused areas do not necessary change the classification or lead to completely different aphasic syndromes. Reperfusion treatment, baseline NIHSS, and lacunar stroke were the main predictors of aphasia recovery.

Identifiants

pubmed: 31439485
pii: S0967-5868(19)31212-3
doi: 10.1016/j.jocn.2019.08.064
pii:
doi:

Substances chimiques

Fibrinolytic Agents 0
Tissue Plasminogen Activator EC 3.4.21.68

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-95

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Alina Menichelli (A)

Rehabilitation Medicine, Department of Medicine, Surgery and Health Services of Trieste, University of Trieste, Trieste, Italy.

Giovanni Furlanis (G)

Clinical Unit of Neurology, Department of Medicine, Surgery and Health Services of Trieste, University of Trieste, Trieste, Italy. Electronic address: giovannifurlanis@yahoo.it.

Arianna Sartori (A)

Clinical Unit of Neurology, Department of Medicine, Surgery and Health Services of Trieste, University of Trieste, Trieste, Italy.

Mariana Ridolfi (M)

Clinical Unit of Neurology, Department of Medicine, Surgery and Health Services of Trieste, University of Trieste, Trieste, Italy.

Marcello Naccarato (M)

Clinical Unit of Neurology, Department of Medicine, Surgery and Health Services of Trieste, University of Trieste, Trieste, Italy.

Paola Caruso (P)

Clinical Unit of Neurology, Department of Medicine, Surgery and Health Services of Trieste, University of Trieste, Trieste, Italy.

Valentina Pesavento (V)

Rehabilitation Medicine, Department of Medicine, Surgery and Health Services of Trieste, University of Trieste, Trieste, Italy.

Paolo Manganotti (P)

Clinical Unit of Neurology, Department of Medicine, Surgery and Health Services of Trieste, University of Trieste, Trieste, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH